Follow the Burning Rock Biotech Ltd stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €180.4m. The latest transaction was disclosed on 2 April 2026 (Acquisition). Among the most active insiders: Han Yusheng. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Burning Rock Biotech Ltd es una empresa centrada en el desarrollo de soluciones de diagnóstico molecular para el cáncer. Cotiza en el NASDAQ bajo el ticker BNR.